Tag:

House Committee on Oversight and Reform

USA Government Regulations - FDA, Customs, etc..
The FDA’s Hypocrisy: Blocking Access to WHO-Approved Pharmaceuticals While Allowing Unregulated Research Chemicals

by Brian Rogers May 31, 2024

by Brian Rogers May 31, 2024

The FDA, tasked with protecting public health, faces criticism for its double standards in regulatory …

Read more

Not-For-Profit Affordable Healthcare and Pharmaceutical Advocacy

Ashvin Medicara is committed to promoting health equity by educating the public about generic medications and advocating for affordable healthcare. We welcome the opportunity to collaborate with the Food and Drug Administration (FDA), U.S. Customs and Border Protection (CBP), U.S. Congress, Drug Enforcement Administration (DEA), and Indian pharmacy groups such as the Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers' Association (IDMA), Pharmaceuticals Export Promotion Council of India (Pharmexcil), Central Drugs Standard Control Organization (CDSCO), and the Department of Pharmaceuticals, ensuring we find a middle ground to deliver quality medications within the bounds of the law.

00:00

Queue

Update Required Flash plugin

00:00